Health and Fitness Health and Fitness
Mon, November 8, 2010
[ Mon, Nov 08th 2010 ] - Market Wire
Targacept Scientists to Present Data Supporting t .. tics for the Treatment of Nervous System Diseases
[ Mon, Nov 08th 2010 ] - Market Wire
CardioNet, Inc. Announces Definitive Merger Agreement with Biotel, Inc.
[ Mon, Nov 08th 2010 ] - Market Wire
Clinical Data, Inc. Launches FAMILION® Genetic T .. ompaction and Long QT Syndrome Large Deletion/Dup
[ Mon, Nov 08th 2010 ] - Market Wire
CPEX Pharmaceuticals Reports Third-Quarter 2010 Financial Results
[ Mon, Nov 08th 2010 ] - Market Wire
CytRx Reports Third Quarter Financial Results
[ Mon, Nov 08th 2010 ] - Market Wire
Progenics Pharmaceuticals Announces Third Quarter 2010 Financial Results
[ Mon, Nov 08th 2010 ] - Market Wire
Micromet to Advance BiTE Antibody MT112/BAY 20101 .. ical Development Activities in Collaboration with
[ Mon, Nov 08th 2010 ] - Market Wire
Medisafe 1 Technologies' Presentation on Newly Launched Company Website
[ Mon, Nov 08th 2010 ] - Market Wire
Transdel Pharmaceuticals Reports Third Quarter and Year-to-Date 2010 Results
[ Mon, Nov 08th 2010 ] - Market Wire
IsoRay Awarded More Than $526,000 in Federal Grants for Breast, Brain and Lung Cancer
[ Mon, Nov 08th 2010 ] - Market Wire
Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
[ Mon, Nov 08th 2010 ] - Market Wire
GTx Appoints Dr. Barry Furr to the Board of Directors
[ Mon, Nov 08th 2010 ] - Market Wire
BioCryst to Present New Data for BCX4208 Monother .. an College of Rheumatology (ACR) Scientific Meeti
[ Mon, Nov 08th 2010 ] - Market Wire
Community Health Systems, Inc. Announces Amendment and Extension of Credit Agreement
[ Mon, Nov 08th 2010 ] - Market Wire
China Kanghui Holdings Announces Board of Director Changes
Sun, November 7, 2010
[ Sun, Nov 07th 2010 ] - Market Wire
Santarus Announces Positive Top-Line Results in E .. y Evaluating Budesonide MMX in Ulcerative Colitis
Sat, November 6, 2010
[ Sat, Nov 06th 2010 ] - Market Wire
GlaxoSmithKline and XenoPort Respond to FDA on Horizanta" for RLS
[ Sat, Nov 06th 2010 ] - Market Wire
XenoPort Announces New Employment Inducement Award
Fri, November 5, 2010
[ Fri, Nov 05th 2010 ] - Market Wire
Alkermesa? Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference
[ Fri, Nov 05th 2010 ] - Market Wire
Heightened Interest from the Medical Research Com .. ernational Stem Cell Corporationa?s (ISCO) Therap
[ Fri, Nov 05th 2010 ] - Market Wire
Osiris Therapeutics Reports Third Quarter 2010 Financial Results
[ Fri, Nov 05th 2010 ] - Market Wire
Dr. Paul Berg to Retire from Gilead Sciencesa? Board of Directors
[ Fri, Nov 05th 2010 ] - Market Wire
Positron Announces Completion of Cardio-Assista"; Set for Early 2011 Deployment
[ Fri, Nov 05th 2010 ] - Market Wire
Exact Sciences Prices Public Offering of Common Stock
[ Fri, Nov 05th 2010 ] - Market Wire
CORRECTING and REPLACING Response Genetics, Inc. Reports Third Quarter 2010 Financial Results
[ Fri, Nov 05th 2010 ] - Market Wire
ZIOPHARM Reports Third Quarter Financial Results and Updates Clinical Programs
[ Fri, Nov 05th 2010 ] - Market Wire
Orthovita to Present at the Maxim Group 4th Annual Growth Conference
[ Fri, Nov 05th 2010 ] - Market Wire
Alnylam Grants New InterfeRxTM Intellectual Prope .. evelopment and Commercialization of TKM-Ebola, an
[ Fri, Nov 05th 2010 ] - Market Wire
ARCA biopharma Awarded $489,000 Grant under Qualifying Therapeutic Discovery Project
[ Fri, Nov 05th 2010 ] - Market Wire
Emergent BioSolutions Receives Orphan Drug Design .. Monoclonal Antibody for the Treatment of Inhalat
[ Fri, Nov 05th 2010 ] - Market Wire
Synta Pharmaceuticals Reports Third-Quarter 2010 Financial Results and Clinical Update
[ Fri, Nov 05th 2010 ] - Market Wire
Abiomed Reports Record Revenues of $23.4 Million, up 17% for Second Quarter of Fiscal 2011
[ Fri, Nov 05th 2010 ] - Market Wire
Columbia Laboratories Reports Third Quarter 2010 Financial Results
Thu, November 4, 2010
[ Thu, Nov 04th 2010 ] - Market Wire
PRESCIENT NEUROPHARMA INC. ANNOUNCES STOCK OPTION GRANT
[ Thu, Nov 04th 2010 ] - Market Wire
Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2010
[ Thu, Nov 04th 2010 ] - Market Wire
Exelixis Announces Third Quarter 2010 Financial Results
[ Thu, Nov 04th 2010 ] - Market Wire
Targacept Reports Third Quarter 2010 Financial Results
[ Thu, Nov 04th 2010 ] - Market Wire
Obagi Medical Products' Third Quarter 2010 Net Sales Rise 12 Percent
[ Thu, Nov 04th 2010 ] - Market Wire
Alkermes Reports Second Quarter Fiscal 2011 Financial Results
[ Thu, Nov 04th 2010 ] - Market Wire
RehabCare to Present at the Stephens Fall Investor Conference 2010
[ Thu, Nov 04th 2010 ] - Market Wire
GenMark Reports Third Quarter Results
[ Thu, Nov 04th 2010 ] - Market Wire
InSite Vision Reports Third Quarter 2010 Financial Results
[ Thu, Nov 04th 2010 ] - Market Wire
Chesley Files Class Action Against DePuy Orthopaedics
[ Thu, Nov 04th 2010 ] - Market Wire
Nasdaq Panel Grants American Learning Corporationa?s Request for Continued Listing
[ Thu, Nov 04th 2010 ] - Market Wire
El Senado de California proclama la semana del 7 .. 3 de noviembre como Semana Educativa sobre la CKD
[ Thu, Nov 04th 2010 ] - Market Wire
Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference
[ Thu, Nov 04th 2010 ] - Market Wire
Medtronic Marks Bladder Health Awareness Month with National Womena?s Health Campaign
[ Thu, Nov 04th 2010 ] - Market Wire
Chemed Corporation to Present at the 2010 Annual Credit Suisse Healthcare Conference
Wed, November 3, 2010
[ Wed, Nov 03rd 2010 ] - Market Wire
Kahn Swick & Foti, LLC and Former Louisiana State .. stors With Large Financial Interests (Over $100,0
[ Wed, Nov 03rd 2010 ] - Market Wire
La vacuna contra el dengue de Sanofi Pasteur est en fase final de desarrollo clnico
[ Wed, Nov 03rd 2010 ] - Market Wire
Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
[ Wed, Nov 03rd 2010 ] - Market Wire
SurModics and Edge Therapeutics Collaborate on De .. lopment of Sustained-Release Neurological Product
[ Wed, Nov 03rd 2010 ] - Market Wire
Teleflex to Present at the Credit Suisse 2010 Healthcare Conference
[ Wed, Nov 03rd 2010 ] - Market Wire
Eugene Melnyk Delivers Notice of Appeal in OSC Matter
[ Wed, Nov 03rd 2010 ] - Market Wire
Community Health Systems to Participate in Credit Suisse 2010 Healthcare Conference
[ Wed, Nov 03rd 2010 ] - Market Wire
Illumina Introduces TruSeqa" Sample Prep and Exome Enrichment Kits
[ Wed, Nov 03rd 2010 ] - Market Wire
AVEO Pharmaceuticalsa? Tivozanib Recognized as On .. ndhovera?s 2011 Top 10 Oncology Projects to Watch
[ Wed, Nov 03rd 2010 ] - Market Wire
Fibrocell Science, Inc. Establishes Joint Venture to Market Its Technology Platform in Asia
[ Wed, Nov 03rd 2010 ] - Market Wire
CardioNet, Inc. Announces National Reimbursement Rate for Mobile Cardiovascular Telemetry
[ Wed, Nov 03rd 2010 ] - Market Wire
Orthovita Reports 2010 Third Quarter Financial Results And Updates Full Year Financial Guidance
[ Wed, Nov 03rd 2010 ] - Market Wire
BioCryst Awarded $1.1 Million in Grants for Qualifying Therapeutic Development Projects
[ Wed, Nov 03rd 2010 ] - Market Wire
Curis Awarded $500,000 in Grants Under the Patient Protection and Affordable Care Act
[ Wed, Nov 03rd 2010 ] - Market Wire
TSO3 ANNOUNCES FINANCIAL RESULTS FOR Q3 2010
Tue, November 2, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
Teva Reports Record Third Quarter 2010 Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Insight Imaging Reports Discussions on Potential Restructuring Plan
[ Tue, Nov 02nd 2010 ] - Market Wire
Los compuestos en fase de investigacin GS 9190 y .. tamiento de la hepatitis C en combinacin con trat
[ Tue, Nov 02nd 2010 ] - Market Wire
Array BioPharma to Report Financial Results for t .. First Quarter of Fiscal 2011 on November 8, 2010
[ Tue, Nov 02nd 2010 ] - Market Wire
GenMark Diagnostics Acquires License to HCV Genotyping Patent Estate
[ Tue, Nov 02nd 2010 ] - Market Wire
SurModics to Webcast Fourth Quarter and Fiscal Year 2010 Earnings Conference Call November 10
[ Tue, Nov 02nd 2010 ] - Market Wire
Corgenix to Host Conference Call to Discuss First Quarter Results
[ Tue, Nov 02nd 2010 ] - Market Wire
Notice of Medical Facilities Corporation';s Fisca .. 0 Third Quarter Financial Results Conference Call
[ Tue, Nov 02nd 2010 ] - Market Wire
WellCare Board Adopts Majority Voting Standard for Director Elections
[ Tue, Nov 02nd 2010 ] - Market Wire
Aeolus Pharmaceuticalsa? AEOL 10150 Promotes Surv .. man Primates Exposed to Lethal Doses of Radiation
[ Tue, Nov 02nd 2010 ] - Market Wire
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Qua .. er 2010 Financial Results Call Set for November 9
[ Tue, Nov 02nd 2010 ] - Market Wire
Tolerx Forms Scientific Advisory Board to Advance Research in Type 1 Diabetes
[ Tue, Nov 02nd 2010 ] - Market Wire
Coventry Health Care, Expeditors International, A .. source Bergen, Principal Financial and Kellogga?s
[ Tue, Nov 02nd 2010 ] - Market Wire
Neurocrine Biosciences, Jacobs Engineering, Ford, Kellogg and Honda Motor Co.
[ Tue, Nov 02nd 2010 ] - Market Wire
DUSA Pharmaceuticals, Inc.® to Host Third Quarte .. Highlights and Financial Results Conference Call
Mon, November 1, 2010
[ Mon, Nov 01st 2010 ] - Market Wire
Prestige Brands Holdings, Inc. Completes Purchase of Blacksmith Brands
[ Mon, Nov 01st 2010 ] - Market Wire
Biomagnetics Completes Audit and Financial Review
[ Mon, Nov 01st 2010 ] - Market Wire
NeoStem to Present at Cell Therapy Industry Summi .. eld on November 3-5, 2010 in Carlsbad, California
[ Mon, Nov 01st 2010 ] - Market Wire
Clinical Data, Inc. Granted Orphan Drug Designati .. for PRX-8066 for Pulmonary Arterial Hypertension
[ Mon, Nov 01st 2010 ] - Market Wire
Health Management Associates, Inc. to Present at the Oppenheimer 21st Annual Healthcare Conference
[ Mon, Nov 01st 2010 ] - Market Wire
Two Directors Step Down from Elan Board in Accordance with Previously Announced Intention
[ Mon, Nov 01st 2010 ] - Market Wire
I composti sperimentali per l'epatite C di Gilead .. azione con terapie standard di cura ottengono una
[ Mon, Nov 01st 2010 ] - Market Wire
Theragenics to Report Third Quarter 2010 Financial Results Tuesday, November 9
[ Mon, Nov 01st 2010 ] - Market Wire
Orthovita to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Mon, Nov 01st 2010 ] - Market Wire
ARIAD to Webcast Conference Call on Third Quarter 2010 Financial Results
[ Mon, Nov 01st 2010 ] - Market Wire
Hepatitis-C-Prfprparate GS 9190 und GS 9256 von G .. Phase II zusammen mit Standardtherapien wesentli
[ Mon, Nov 01st 2010 ] - Market Wire
American Anesthesiology Announces the Acquisition of Greensboro, NC, Group Practice
[ Mon, Nov 01st 2010 ] - Market Wire
Inhibitex Initiates Phase 1b Multiple Ascending D .. l of INX-189 in Patients with Chronic Hepatitis C
[ Mon, Nov 01st 2010 ] - Market Wire
Medisafe 1 Technologies Appoints Tali Skoczylas as Chair of Medical Advisory Board
[ Mon, Nov 01st 2010 ] - Market Wire
Porex Corporation Divests Surgical Division to Stryker Corporation
Sat, October 30, 2010
[ Sat, Oct 30th 2010 ] - Market Wire
A Celgene anuncia resultados financeiros e operacionais recordes no terceiro trimestre de 2010
[ Sat, Oct 30th 2010 ] - Market Wire
Viread® for Hepatitis B Maintains Antiviral Supp .. ent of Resistance Through Four Years of Treatment
[ Sat, Oct 30th 2010 ] - Market Wire
Gileada?s Investigational Hepatitis C Compounds G .. tion with Standard of Care Therapies Achieve Subs
[ Sat, Oct 30th 2010 ] - Market Wire
Salix Pharmaceuticals Previews Data Slated for Pr .. ting of the American Association for the Study of
[ Sat, Oct 30th 2010 ] - Market Wire
New Data From Phase 3 Studies Showed Superior SVR .. with Telaprevir-Based Combination Therapy in Peop
Fri, October 29, 2010
[ Fri, Oct 29th 2010 ] - Market Wire
Fitch Affirms Boston Scientific's IDR at 'BB+'; Outlook to Positive
[ Fri, Oct 29th 2010 ] - Market Wire
Teva Invites Public to Listen to Its Respiratory Opportunity Meeting Webcast
[ Fri, Oct 29th 2010 ] - Market Wire
Ligand to Report Third Quarter Results on November 9
[ Fri, Oct 29th 2010 ] - Market Wire
St. Jude Medical???2010??????????????
[ Fri, Oct 29th 2010 ] - Market Wire
Celgene meldet rekordverdchtiges Betriebs- und Finanzergebnis fr das dritte Quartal 2010
[ Fri, Oct 29th 2010 ] - Market Wire
Seattle Genetics to Present at Oppenheimer Healthcare Conference
[ Fri, Oct 29th 2010 ] - Market Wire
Idera Pharmaceuticals Appoints Sudhir Agrawal as .. Directors and William S. Reardon as Lead Director
[ Fri, Oct 29th 2010 ] - Market Wire
Alnylam Scientists to Present New Data on RNAi Th .. Meeting of the American Association for the Stud
[ Fri, Oct 29th 2010 ] - Market Wire
MannKind Corporation Reports 2010 Third Quarter Financial Results
[ Fri, Oct 29th 2010 ] - Market Wire
Abstracts Highlighting Data from Enzona?s mRNA An .. d for Presentation at 2010 EORTC-NCI-AACR Meeting
[ Fri, Oct 29th 2010 ] - Market Wire
Celgene Corporation to Present at Oppenheimera?s 21st Annual Healthcare Conference
[ Fri, Oct 29th 2010 ] - Market Wire
Compugen Licenses Novel Oncology Target to Seattle Genetics
[ Fri, Oct 29th 2010 ] - Market Wire
Magellan Health Services Reports Third Quarter 2010 Financial Results
[ Fri, Oct 29th 2010 ] - Market Wire
Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
Thu, October 28, 2010
[ Thu, Oct 28th 2010 ] - Market Wire
AGA Medical to Report Third Quarter Earnings on Monday, November 8, 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Urologix to Host Its Fiscal 2011 First Quarter Conference Call
[ Thu, Oct 28th 2010 ] - Market Wire
Exact Sciences Reports Positive Results for Colorectal Cancer Screening Test
[ Thu, Oct 28th 2010 ] - Market Wire
Health Net Expands Mobile Capabilities
[ Thu, Oct 28th 2010 ] - Market Wire
Emeritus Corporation to Host Third Quarter 2010 Earnings Conference Call and Webcast
[ Thu, Oct 28th 2010 ] - Market Wire
ArthroCare Receives FDA Clearance for Spartan PEEK Suture Implant
[ Thu, Oct 28th 2010 ] - Market Wire
Celgene Reports Record Third Quarter 2010 Operating and Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
Celgene comunica risultati finanziari e operativi record per il terzo trimestre del 2010
[ Thu, Oct 28th 2010 ] - Market Wire
Natus Medical Announces 2010 Third Quarter Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
Curis Reports Third Quarter 2010 Financial Results
[ Thu, Oct 28th 2010 ] - Market Wire
Pro-Pharmaceuticals Ships First Commercial Order for DAVANAT®
[ Thu, Oct 28th 2010 ] - Market Wire
ACADIA Pharmaceuticals Enters Agreement with Biov .. and Regain North American Rights to Pimavanserin
[ Thu, Oct 28th 2010 ] - Market Wire
BioCryst Reports Third Quarter 2010 Financial Results and Provides Corporate Update
[ Thu, Oct 28th 2010 ] - Market Wire
AngioDynamics Announces Election of Kevin J. Gould to Board of Directors
Wed, October 27, 2010
[ Wed, Oct 27th 2010 ] - Market Wire
Crown Oil and Gas Announces Appointment of Director
[ Wed, Oct 27th 2010 ] - Market Wire
Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ] - Market Wire
Northstar Healthcare Announces Senior Management Changes
[ Wed, Oct 27th 2010 ] - Market Wire
Neue therapeutische Oberflche von KCI verbessert .. tegritt fr Prvention und Management von Dekubitus
[ Wed, Oct 27th 2010 ] - Market Wire
Nuova superficie terapeutica sviluppata da KCI ri .. la prevenzione e la gestione delle piaghe da dec
[ Wed, Oct 27th 2010 ] - Market Wire
ZIOPHARM Oncology to Present at Oppenheimer 21st Annual Healthcare Conference
[ Wed, Oct 27th 2010 ] - Market Wire
Bond Labsa? Resurrectiona" Conducts In-Store Promotions for Cub Foods®
[ Wed, Oct 27th 2010 ] - Market Wire
Successful IsoRay Study of Cesium-131 Internal Ra .. Breast CancerPaves the Way for Advanced Treatment
[ Wed, Oct 27th 2010 ] - Market Wire
Exact Sciences Reports Third-Quarter 2010 Financial Results
[ Wed, Oct 27th 2010 ] - Market Wire
St. Jude Medical to Showcase Portfolio of Products at Asia-Pacific Heart Rhythm 2010
[ Wed, Oct 27th 2010 ] - Market Wire
Salix Pharmaceuticals Launches Corporate Twitter Account and Facebook Page
[ Wed, Oct 27th 2010 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES THE NOMINATION OF ADDITIONAL MEMBERS TO THE BOARD OF DIRECTORS
[ Wed, Oct 27th 2010 ] - Market Wire
BioCrysta?s Partner Shionogi Receives Approval for Pediatric Use Of Peramivir in Japan
[ Wed, Oct 27th 2010 ] - Market Wire
Santarus to Hold Third Quarter 2010 Financial Results Conference Call on November 8
Tue, October 26, 2010
[ Tue, Oct 26th 2010 ] - Market Wire
IPC The Hospitalist Company CEO Dr. Adam Singer Named MGMA-ACMPE Physician Executive of the Year
[ Tue, Oct 26th 2010 ] - Market Wire
ARIAD Announces Pricing of Public Offering of Common Stock
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and Bend Research Enter into Collaboration to .. ion Development and Analytical Testing Capabiliti
[ Tue, Oct 26th 2010 ] - Market Wire
PPD and VirtualScopics Establish Strategic Alliance for Medical Imaging Services
[ Tue, Oct 26th 2010 ] - Market Wire
Obagi Medical Products Announces Proposed Seconda .. ockholders and Authorization to Repurchase Shares
[ Tue, Oct 26th 2010 ] - Market Wire
Life Technologies Establishes New Standard for Single-Read Accuracy in Next Generation Sequencing
[ Tue, Oct 26th 2010 ] - Market Wire
Oncolytics Biotech® Inc. Collaborators Prese .. al Colorectal Cancer Study at the International S
[ Tue, Oct 26th 2010 ] - Market Wire
Exelixis Announces November 4 Webcast of Third Quarter 2010 Financial Results Conference Call
[ Tue, Oct 26th 2010 ] - Market Wire
Biogen Idec Reports Third Quarter 2010 Results
[ Tue, Oct 26th 2010 ] - Market Wire
Amedisys Reports Third Quarter Revenue and Earnings, Updates 2010 Guidance
[ Tue, Oct 26th 2010 ] - Market Wire
Compugen Reports Third Quarter 2010 Financial Results
[ Tue, Oct 26th 2010 ] - Market Wire
Synergetics USA Announces New Products and Record .. rican Academy of Ophthalmology 2010 Annual Meetin
[ Tue, Oct 26th 2010 ] - Market Wire
Cascade Technologies Corporation Announces Appointment of Robert Chave as Chief Technologist
[ Tue, Oct 26th 2010 ] - Market Wire
ICON Announces Appointment of Cathrin Petty to Board of Directors
Mon, October 25, 2010
[ Mon, Oct 25th 2010 ] - Market Wire
Ligand to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2
[ Mon, Oct 25th 2010 ] - Market Wire
Quest PharmaTech Announces Treasury Issue of Common Shares
[ Mon, Oct 25th 2010 ] - Market Wire
Synovis Life Technologies to Present at the Singu .. l Best of the Uncovereds Conference on November 4
[ Mon, Oct 25th 2010 ] - Market Wire
Abiomed Second Quarter Fiscal 2011 Earnings and Conference Call Notification
[ Mon, Oct 25th 2010 ] - Market Wire
Helicos BioSciences Amends Patent Infringement La .. ciences to Include Illumina and Life Technologies
[ Mon, Oct 25th 2010 ] - Market Wire
Emeritus to Acquire Rehab Therapy Services Group
[ Mon, Oct 25th 2010 ] - Market Wire
Seattle Genetics and Millennium to Highlight Bren .. t the International Symposium on Hodgkin Lymphoma
[ Mon, Oct 25th 2010 ] - Market Wire
BioCryst to Present at Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ] - Market Wire
Bestuur Alcon kiest nieuwe voorzitter
[ Mon, Oct 25th 2010 ] - Market Wire
AngioDynamics to Participate at the 21st Annual Oppenheimer Healthcare Conference
[ Mon, Oct 25th 2010 ] - Market Wire
Il Consiglio di amministrazione di Alcon nomina il suo nuovo Presidente
[ Mon, Oct 25th 2010 ] - Market Wire
Junta de Alcon elige nuevo presidente
[ Mon, Oct 25th 2010 ] - Market Wire
Alcon-Verwaltungsrat whlt neuen Vorsitzenden
[ Mon, Oct 25th 2010 ] - Market Wire
Conselho da Alcon elege novo presidente
Sun, October 24, 2010
[ Sun, Oct 24th 2010 ] - Market Wire
Gileada?s Cayston® superieur aan Tobramycine inh .. anden durende head-to-head cystic fibrosis studie
[ Sun, Oct 24th 2010 ] - Market Wire
Alcon Board Elects New Chairman
[ Sun, Oct 24th 2010 ] - Market Wire
HERBALIFE LANZA NUEVOS PRODUCTOS INCLUYENDO BATID .. EINA SIN ALERGENOS Y SUPLEMENTO NUTRICIONAL COQ10
Sat, October 23, 2010
[ Sat, Oct 23rd 2010 ] - Market Wire
Dr. Reddya?s Q2 FY11 Financial Results
Fri, October 22, 2010
[ Fri, Oct 22nd 2010 ] - Market Wire
Cayston® di Gilead si dimostrato superiore alla .. alazione in uno studio di raffronto diretto della
[ Fri, Oct 22nd 2010 ] - Market Wire
Cayston® von Gilead zeigt in sechsmonatiger Kopf .. Fibrose berlegenheit gegenber Tobramycin-Inhalat
[ Fri, Oct 22nd 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of Clarient, Inc. in Connection with the Propo
[ Fri, Oct 22nd 2010 ] - Market Wire
MannKind Corporation to Hold 2010 Third Quarter F .. ncial Results Conference Call on October 29, 2010
[ Fri, Oct 22nd 2010 ] - Market Wire
Sycamore Entertainment Group Launches New Corporate Website
[ Fri, Oct 22nd 2010 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Clarient Inc. a" CLRT
[ Fri, Oct 22nd 2010 ] - Market Wire
Clarient, Inc. Shareholder Investigation by Brisc .. Regarding the Buyout by General Electric Company
[ Fri, Oct 22nd 2010 ] - Market Wire
Cardiac Science Shareholder Investigation by Bris .. ing the Merger with Opto Circuits (India) Limited
[ Fri, Oct 22nd 2010 ] - Market Wire
Kendall Law Group Investigates Clarient, Inc. Acquisition for Shareholders
[ Fri, Oct 22nd 2010 ] - Market Wire
Wright Medical Group, Inc. Announces Full Commerc .. f PRO-STIMa" Osteoinductive Bone Graft Substitute
[ Fri, Oct 22nd 2010 ] - Market Wire
Health Net Federal Services Awarded Department of .. ns Affairs CBO Outpatient Recovery Audit Contract
[ Fri, Oct 22nd 2010 ] - Market Wire
St. Jude Medical Board of Directors Authorizes Share Repurchase
[ Fri, Oct 22nd 2010 ] - Market Wire
Biogen Idec en Genentech melden herstructurering anti-CD20 samenwerkingsovereenkomst
[ Fri, Oct 22nd 2010 ] - Market Wire
Biogen Idec y Genentech anuncian modificacin en su acuerdo de colaboracin de anticuerpos anti-CD20
Thu, October 21, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
The Shuman Law Firm Announces the Filing of a Cla .. ction Lawsuit against Acura Pharmaceuticals, Inc.
[ Thu, Oct 21st 2010 ] - Market Wire
Emergency Medical Services to Host Conference Cal .. sults for Third Quarter Ending September 30, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Merit Medical Systems to Announce Third Quarter Results on November 4, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Apricus Biosciences to Present at the FSX Investor Conference in Phoenix, AZ on October 29, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
IntegraMed® to Participate at Fifth Annual Singu .. h Best of The Uncovereds Conference on November 4
[ Thu, Oct 21st 2010 ] - Market Wire
PerkinElmer to Hold Earnings Call on Thursday, November 4, 2010
[ Thu, Oct 21st 2010 ] - Market Wire
Orthovita Announces 2010 Third Quarter Product Sales
[ Thu, Oct 21st 2010 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES THE APPOINTMENT .. ICING CARDIOLOGISTS TO SERVE AS BOARD OF ADVISORS
[ Thu, Oct 21st 2010 ] - Market Wire
Laboratory Corporation of America® Holdings Announces 2010 Third Quarter Results
[ Thu, Oct 21st 2010 ] - Market Wire
BioCryst to Present New Clinical & Virologic Data .. or I.V. Peramivir at the 48th Annual IDSA Meeting
[ Thu, Oct 21st 2010 ] - Market Wire
AVEO Pharmaceuticals, Inc. Announces Timing for T .. 10 Financial Results, Webcast and Conference Call
[ Thu, Oct 21st 2010 ] - Market Wire
ImmunoGen, Inc. Announces Conference Call to Disc .. First Quarter Fiscal Year 2011 Financial Results
[ Thu, Oct 21st 2010 ] - Market Wire
Alexion Reports Third Quarter 2010 Results
[ Thu, Oct 21st 2010 ] - Market Wire
Icon Reports Revenues of $225 Million up 2% on Prior Year (Nasdaq:ICLR) (ISIN:IE0005711209)

Seattle Genetics to Present at Oppenheimer Healthcare Conference


//health-fitness.news-articles.net/content/2010/ .. resent-at-oppenheimer-healthcare-conference.html
Published in Health and Fitness on Friday, October 29th 2010 at 6:11 GMT by Market Wire   Print publication without navigation


BOTHELL, Wash.--([ BUSINESS WIRE ])--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that its management will present a company overview at the Oppenheimer 21st Annual Healthcare Conference on Wednesday, November 3, 2010, at 1:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from Seattle Geneticsa™ website, [ www.seattlegenetics.com ], under the aInvestors and Newsa section.

About Seattle Genetics

Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company recently reported positive top-line data from both a pivotal Hodgkin lymphoma trial and phase II anaplastic large cell lymphoma trial with its lead product candidate, brentuximab vedotin, and plans to submit a Biologics License Application to the U.S. Food and Drug Administration in the first half of 2011. Brentuximab vedotin is being developed in collaboration with Millennium: The Takeda Oncology Company. In addition, Seattle Genetics has four other clinical-stage programs: SGN-75, ASG-5ME, dacetuzumab (SGN-40) and SGN-70. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, Millennium: The Takeda Oncology Company and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab. More information can be found at [ www.seattlegenetics.com ].


Publication Contributing Sources